GalenPath is a Reporting Tool for Tumor Analysis that combines molecular data and histopathology to provide comprehensive diagnostic reports.
The tool processes histopathology data, including tissue biopsy results and immunohistochemistry (IHC) findings. It helps pathologists assess the structure and cell types of tumors, providing critical visual and microscopic insights that form the foundation of a cancer diagnosis.
The tool integrates molecular data, including genomic sequencing, gene expression profiles, and biomarker identification (e.g., mutations in oncogenes or tumor suppressor genes). This data helps detect specific genetic alterations driving tumor growth, supporting precision medicine by guiding targeted therapies based on the patient molecular profile.
By combining histopathology with molecular data, the tool enables an integrated diagnosis that considers both the physical characteristics of the tumor and its underlying molecular bio-markers. This comprehensive approach provides a more accurate diagnosis, helping clinicians tailor treatments and predict outcomes based on both data types.
The tool generates an integrated report that merges histopathology and molecular findings into a single document. This report includes diagnostic interpretations and molecular markers offering a comprehensive view for oncologists. The report also supports clinical decision-making, treatment planning, and personalized therapy recommendations.